Novavax Gets Full Marketing Authorization in the EU for Prevention of COVID

 

• Marketing Authorization replaces conditional Marketing Authorization and is first for Novavax in the EU

• Marketing Authorization includes use of Nuvaxovid™ as a primary series in individuals aged 12 and older and booster in adults

• Marketing Authorization provides regulatory foundation for future vaccine updates, including Fall vaccination campaign

https://finance.yahoo.com/news/novavaxs-nuvaxovid-receives-full-marketing-134700291.html